Erik Janssen He has over 20-year of experience in the biopharmaceutical industry, taking on different global leadership responsibilities and operational affiliate responsibilities. He joined UCB in 2005 and is now the global head of the Neurology Patient Relevant Innovative Solutions Mission. This mission is looking into technology solutions that can make a meaningful difference to the lives of people living with neurological conditions like epilepsy and Parkinson. Before that he has been holding several strategic and operational roles at UCB such as leading the global lifecycle team of Keppra, UCB’s first anti-epileptic drug, CNS franchise lead in Germany and other global marketing roles in neurology.
Prior to joining UCB he held the position of Business Unit Director Oncology at Sanofi Aventis and has a significant track record of accomplishments in international sales and marketing. Erikholds a master’s degree in chemistry from the University of Leuven, Belgium. His ambition is to inspire and invite people to create meaningful value for those who face the consequences of living with diseases that significantly impact their lives.